The Role of Sirtl in Vascular Senescence and Funcrion
The Role of Sirtl in Vascular Senescence and Funcrion
批准号:
18590801
负责人:
AKISHITA Masahiro
金额:
$2.48万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2006
资助国家:
日本
项目状态:
已结题
起止时间:
2006 至 2007
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Yeast Sir2 plays critical roles in gene silencing, stress resistance and longevity. Mammalian Sirt1 NAD (+)-dependent protein deacetylase, the closest homolog of Sir2, regulates cell cycle, cellular senescence, apoptosis and metabolism, by functional interactions with a number of biological molecules such as p53. To investigate a role of Sirt1 in endothelial dysfunction and premature senescence, we examined the effects of Sirt1 inhibition in human umbilical vein endothelial cells (HUVEC). Sirt1 inhibition by sirtinol or siRNA for Sirt1-induced premature senescence-like phenotype, as judged by increased senescence-associated beta-galactosidase (SA-beta-gal) activity, sustained growth arrest and enlarged and flattened cell morphology at 10 days after the treatment. Sirt1 inhibition by sirtinol or Sirt1 siRNA increased PAI-1 expression and decreased both protein expression and activity of eNOS. Treatment with sirtinol or Sirt1 siRNA increased acetylation of p53, while p53 expression was unaltered. Impaired epidermal growth factor-induced activation of mitogen-activated protein kinases was associated with Sirt1 inhibition-induced senescence-like growth arrest. Conversely, overexpression of Sirt1 prevented hydrogen peroxide-induced SA-beta-gal activity, morphological changes and deranged expression of PAI-1 and eNOS. Next, we found that cilostazol, a phosphodiesterase 3 inhibitor, exerted protective effects against premature senescence-like phenotype of HUVEC, and NO-dependent Sirt1 expression plays a key role in its effects. We conclude that Sirt1 may exert protective effects against endothelial dysfunction by preventing stress-induced premature senescence.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.ejphar.2008.04.052
发表时间:
2008-07
期刊:
European journal of pharmacology
影响因子:
5
作者:
[Jing Yu;M. Eto;K. Kozaki;M. Akishita;T. Okabe;Y. Ouchi]
通讯作者:
Jing Yu;M. Eto;K. Kozaki;M. Akishita;T. Okabe;Y. Ouchi
Multiple consultations and polypharmacy of patients attending geriatric outpatient units of university hospitals.
大学附属医院老年科门诊患者的多次会诊和多次用药。
DOI:
--
发表时间:
2006
期刊:
Geriatr Gerontol Int 6(4)
影响因子:
--
作者:
[Suzuki Y, Akishita M, Arai H, Teramoto S, Morimoto S, Toba K]
通讯作者:
Toba K
PDE3阻害薬、シロスタゾールによる血管内皮premature senescence抑制作用メカニズム
PDE3抑制剂西洛他唑抑制血管内皮早衰的机制
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[大田秀隆, 江頭正人, 飯島勝矢, 秋下雅弘, 大内尉義]
通讯作者:
大内尉義
Cilostazol, a Selective Inhibitor of PDE3, Blocked Oxidative, Stress-induced Premature Senescence of Human Endothelial Cells
西洛他唑是一种 PDE3 选择性抑制剂,可阻断氧化、应激诱导的人内皮细胞过早衰老
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[Ota H, Eto M, Mukoda O, Iijima K, Akishita M, Ouchi Y]
通讯作者:
Ouchi Y
Cilostazol, a Selective Inhibitor of PDE3, Inhibited Oxidative Stress-induced Premature Senescence of Human Endothelial Cells
西洛他唑 (Cilostazol) 是一种 PDE3 选择性抑制剂,可抑制氧化应激诱导的人内皮细胞过早衰老
DOI:
--
发表时间:
2007
期刊:
影响因子:
--
作者:
[Ota H, Eto M, Ogawa S, Iijima K, Akishita M Ouchi Y]
通讯作者:
Akishita M Ouchi Y
共 15 条
Investigation into functional mechanisms of herbal medicines with attention to sex hormonal effects - towards the development of anti-ageing drugs -
-
批准号:24390180
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.32万
-
财政年份:2012
-
负责人:AKISHITA Masahiro
-
依托单位:
A correlative biomarker analysis of demented Patient's QOL.
-
批准号:23659376
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.16万
-
财政年份:2011
-
负责人:AKISHITA Masahiro
-
依托单位:
Investigation on the protective action of androgen on aging and age-related diseases : from cellular senescence to frailty
-
批准号:21390220
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.48万
-
财政年份:2009
-
负责人:AKISHITA Masahiro
-
依托单位:
Role of the renin angiotensin system in oxidative stress-induced endothelial cell apoptosis
-
批准号:13670741
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2001
-
负责人:AKISHITA Masahiro
-
依托单位:
国内基金
海外基金
登录
查看更多内容
HIF-1α调控软骨细胞衰老在骨关节炎进展中的作用及机制研究
-
批准号:82371603
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈晓
-
依托单位:
间皮细胞衰老在腹膜透析后腹膜适应不良修复和纤维化发病中的作用及机制研究
-
批准号:82370743
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姜娜
-
依托单位:
衰老抑制脊髓损伤修复的CXCL13依赖性CD8+T细胞通讯机制研究
-
批准号:82371585
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:周鲁明
-
依托单位:
衰老上皮细胞FABP4调控HSDL2致脂肪酸代谢失衡在BPH发病中的机制研究
-
批准号:82370774
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:阮渊
-
依托单位:
LMNA基因R527C纯合突变儿童早老症干细胞功能异常及分子机理研究
-
批准号:32100603
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:周焱
-
依托单位:
NRF2/MFN2/ERS信号异常促进ADSCs衰老和肥大型肥胖皮下脂肪组织胰岛素抵抗的机制研究
-
批准号:32000511
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:方佳
-
依托单位:
SIRT2在灵长类心肌衰老进程中的作用及其机制研究
-
批准号:32000510
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:范艳玲
-
依托单位:
隐性遗传方式儿童早老症患者SASP-like炎症反应病理特征和分子机制研究
-
批准号:32060157
-
项目类别:地区科学基金项目
-
资助金额:36.0万元
-
批准年份:2020
-
负责人:舒伟
-
依托单位:
c-Fos在皮肤上皮干细胞衰老中的作用研究
-
批准号:32070730
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:张亮
-
依托单位:
SETD8介导H4K20单甲基化修饰对MSCs抗衰老的作用机制
-
批准号:32060156
-
项目类别:地区科学基金项目
-
资助金额:36.0万元
-
批准年份:2020
-
负责人:刘鹏霞
-
依托单位: